InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Baldry Mark. Officer active across 1 company, notably X4 Pharmaceuticals, Inc. Cumulatively, 8 filings have been recorded. Breakdown: 2 buys · 2 sells. Total volume traded: €29k. Activity tracked since 31 October 2023. The latest transaction was disclosed on 16 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Baldry Mark has 7 filings in total. In the 7 most recent filings we hold, related to X4 Pharmaceuticals, Inc, the reported buy and sell amounts are EUR 15773 and EUR 13005, respectively, over the period from 2023-11-02 to 2025-05-20. Their primary role is not provided, and the most common transaction nature is Attribution.